Physician profile
Adam C Kaufman
NPI 1114313426
$4,180.50
in general payments reported to CMS, 2019-2025
7 companies · $2,766 in 2025
The $2,766 reported for 2025 was more than what 81% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $778 · 2023: $267 · 2024: $370 · 2025: $2,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $1,378 · Gift: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $1,377.70 |
| Gift | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $2,000.00 | 2025 | |
| Stryker Corporation | $891.32 | 2023-2025 | Na, Direct Inject, Adherus Autospray Et Dural Sealant |
| Cochlear Americas | $845.58 | 2022-2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Integra Lifesciences Corporation | $214.57 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Inspire Medical Systems, INC. | $140.11 | 2025 | Inspire |
| Advanced Bionics, LLC | $63.92 | 2022 | |
| Haag-Streit USA, INC. | $25.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.